#53 – Abscessus and fortuitum and avium, Oh My!: Updates and Controversies in NTM Management
Breakpoints18 Helmi 2022

#53 – Abscessus and fortuitum and avium, Oh My!: Updates and Controversies in NTM Management

Drs. Wendi Drummond and Jeff Pearson (@jeffpears0n) join Dr. Rachel Britt (@RachelBPharmD) on the Breakpoints podcast this week to discuss all things on non-tuberculosis mycobacteria pulmonary infections. Listen for answers to all your burning questions like “Are we still using IV amikacin?” and “How do I get omadacycline for my patient?” as well as learning why clofazimine is the coolest drug out there. For more NTM content, check out Dr. Drummond’s podcast, NTMTalk!

This podcast was sponsored by an unrestricted medical education grant from Paratek.

Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/

References:

  1. www.doi.org/10.1093/cid/ciaa241
  2. www.doi.org/10.1164/rccm.200604-571ST
  3. www.doi.org/10.1136/thoraxjnl-2015-207360
  4. www.doi.org/10.1136/thoraxjnl-2017-210927
  5. www.doi.org/10.1093/ofid/ofaa415
  6. www.doi.org/10.1093/ofid/ofab002
  7. https://clinicaltrials.gov/ct2/show/NCT04922554

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(135)

#47 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 2

#47 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 2

From generating 150 liters-worth of E. coli to the first X-ray crystallography of an ESBL, Drs. Robert Bonomo, Ryan Shields (@ryankshields), and Erin McCreary (@ErinMcCreary) take a deep dive into bet...

29 Loka 20210s

#46 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 1

#46 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 1

Mechanisms of antibiotic resistance help us understand and recognize antibiotic susceptibility patterns that don't make sense. Robert Bonomo and Ryan Shields (@ryankshields) join Erin McCreary (@ErinM...

22 Loka 20210s

#45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials

#45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials

Pathogen-directed trials are among the most important trials that clinicians need to guide therapy but are also incredibly difficult to design and enroll. Rachel Britt (@RachelBPharmD) gets a behind-...

24 Syys 20210s

#44 – The VaxScene, a review of the COVID-19 vaccine landscape in the US with a focus on equitable distribution and vaccine hesitancy

#44 – The VaxScene, a review of the COVID-19 vaccine landscape in the US with a focus on equitable distribution and vaccine hesitancy

Jacinda Abdul-Mutakabbir (@jayCdoesID) and Jeannette Bouchard (@jlbouchard001) join Erin McCreary (@ErinMcCreary) to discuss COVID vaccines, including access to, confidence in, and hesitancy around th...

17 Syys 20210s

#43 – Level Up: Implementation of Beta-lactam Therapeutic Drug Monitoring

#43 – Level Up: Implementation of Beta-lactam Therapeutic Drug Monitoring

Erin McCreary (@erinmccreary) reviews clinical data and implementation strategies for therapeutic drug monitoring of beta-lactam antibiotics with Veena Venugopalan (@Veena_PharmD), Joseph Kuti, Jason ...

27 Elo 20211h 2min

#42 – The Level is in the Details:  Beta-lactam Therapeutic Drug Monitoring

#42 – The Level is in the Details: Beta-lactam Therapeutic Drug Monitoring

Erin McCreary (@erinmccreary) discusses clinical rationale behind therapeutic drug monitoring of beta-lactam antibiotics with Veena Venugopalan (@Veena_PharmD), Joseph Kuti, Jason Roberts (@jasonrober...

20 Elo 202155min

#41 – The Gray Zone: Antimicrobial Stewardship in Immunocompromised Hosts

#41 – The Gray Zone: Antimicrobial Stewardship in Immunocompromised Hosts

Promoting evidence-based antimicrobial stewardship for patients with immunocompromising conditions can be tricky when they’re often excluded from clinical studies. Dr. Zahra Kassamali Escobar (@ZKEPha...

16 Heinä 20210s

#40 – Breakpoints Talks Breakpoints: Microbiology Labs and Stewardship

#40 – Breakpoints Talks Breakpoints: Microbiology Labs and Stewardship

In this episode, host Dr. Erin McCreary (@erinmccreary) talks all things micro labs and stewardship with Dr. Romney Humphries (@romneyinla), Dr. Mary Hutton (@m3rkat), and Dr. Joseph Lutgring. From ca...

18 Kesä 20211h 13min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
adhd-podi
rss-rahamania
rss-liian-kuuma-peruna
psykologia
rss-laadukasta-ensihoitoa
rss-narsisti
rss-vapaudu-voimaasi
kesken
rss-niinku-asia-on
rss-arkea-ja-aurinkoa-podcast-espanjasta
rss-hereilla
rahapuhetta
rss-keskeneraiset-aidit
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-duodecim-lehti
rss-valo-minussa-2
rss-tfa-8020-podcast